Archive: 23/08/2018

First drug approved for rare eye disease

(HealthDay)—Oxervate (cenegermin) has been approved by the U.S. Food and Drug Administration to treat neurotrophic keratitis, a rare disease of the eye's cornea.

page 2 from 9